Skip to content

HelpLine 1-800-298-2436 support@go2.org
General Questions 650-598-2857 info@go2.org

About
Research
Blog
Advocacy
For Professionals
Donate

Search for:

Search for:

Home
What is Lung Cancer
Risk & Early Detection
Treatments & Side Effects
Resources & Support
Get Involved

Search for:

2019 final day

Bethany Johnson (GO2 for Lung Cancer)2020-07-13T17:13:14-05:00July 13th, 2020|0 Comments

Share

Facebook Twitter LinkedIn Tumblr Pinterest Email

Leave A Comment Cancel reply

Comment

The reCAPTCHA verification period has expired. Please reload the page.

Δ

Categories

Advocacy in Action
Community Engagement
Hot Topics
News
Newsletter Articles
Press Releases
Science and Research
- Small Cell Lung Cancer
Spotlights
Stories of Hope

Recent Posts

GO2 for Lung Cancer Statement on the ‘One Big Beautiful Bill Act’ and Its Impact on Lung Cancer Care Access
The Unbreakable Bond of a Survivor and Nurse Navigator
Speaking Out, Showing Up, and Shifting the Narrative
Breaking News: Supreme Court Preserves No-Cost Lung Cancer Screening—But Vigilance Is Still Needed
FDA Approves Datroway (datopotamab deruxtecan-dlnk) for EGFR-positive NSCLC

Archives

Archives

© 2022 GO2 for Lung Cancer. The information presented in this website is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you get from this website.

About Us
Research
Blog
Advocacy
For Professionals
HelpLine: 1-800-298-2436
General Questions: 202-463-2080 and 650-598-2857

Stay Informed!

Sign up to receive GO2 emails to help guide you through our resources, connection opportunities, and support.